@prefix dcterms: . @prefix ns1: . @prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix nt: . @prefix xsd: . @prefix rdfs: . @prefix orcid: . @prefix bl: . @prefix nkg: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { bl:category bl:Disease . sub:association rdf:object ; rdf:predicate bl:treats; rdf:subject ; a rdf:Statement; rdfs:label "for endometriosis see reverse side synarel is indicated for treatment of central precocious puberty cpp the diagnosis of central precocious puberty cpp for central precocious puberty see reverse side synarel is indicated for management of endometriosis including pain relief and reduction of endometriotic lesions experience with synarel for the management of endometriosis has been limited to women 18 years of age and older treated for 6 months"; bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation; bl:provided_by ; bl:relation nkg:SymptomaticReliefIndication . bl:category bl:Drug . } sub:provenance { sub:assertion ns1:wasAttributedTo orcid:0000-0002-1468-3557 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"; npx:hasSignature "i1kCN/Is7g28MDz/ohysKHcy5mFFgkDhPWRAtYxWgRE7fFYq/gceCcbqmftXXm6Xhj7IIOSvmohyAIM+9/gnN0whcCbBjgXYOYMkS47SC6LOBrNvNDXL8JpfKaf8a95hq9qXjjh+uAX+VhSLH8XjYGfMN4xRwVVOZsw+vuOVQLM="; npx:hasSignatureTarget this: . this: dcterms:created "2021-06-27T21:41:31.854+02:00"^^xsd:dateTime; dcterms:creator orcid:0000-0002-1468-3557; nt:wasCreatedFromProvenanceTemplate ; nt:wasCreatedFromPubinfoTemplate ; nt:wasCreatedFromTemplate . }